NCT02016131View on ClinicalTrials.gov

CQDSA in Evaluation of Prognosis After EVAR

CompletedOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

March 31, 2015

Conditions
EndoleakAortic Aneurysm, Abdominal
Trial Locations (1)

200032

Zhongshan Hospital, Shanghai

All Listed Sponsors
collaborator

Siemens Ltd., China, Shanghai, China.

UNKNOWN

lead

Shanghai Zhongshan Hospital

OTHER

NCT02016131 - CQDSA in Evaluation of Prognosis After EVAR | Biotech Hunter | Biotech Hunter